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Purpose: To report the clinical and genetic study of patients with autosomal dominant aniridia.
Methods: We studied ten patients with aniridia from three families of Egyptian origin. All patients underwent full
ophthalmologic, general and neurological examination, and blood drawing. Cerebral magnetic resonance imaging was
performed in the index case of each family. Genomic DNA was prepared from venous leukocytes, and direct sequencing
of all the exons and intron–exon junctions of the Paired Box gene 6 (PAX6) was performed after PCR amplification.
Phenotype description, including ophthalmic and cerebral anomalies, mutation detection in PAX6 and phenotype-genotype
correlation was acquired.
Results: Common features observed in the three families included absence of iris tissue, corneal pannus with different
degrees of severity, and foveal hypoplasia with severely reduced visual acuity. In Families 2 and 3, additional findings,
such as lens dislocation, lens opacities or polar cataract, and glaucoma, were observed. We identified two novel (c.
170-174delTGGGC [p.L57fs17] and c.475delC [p.R159fs47]) and one known (c.718C>T [p.R240X]) PAX6 mutations
in the affected members of the three families. Systemic and neurological examination was normal in all ten affected
patients. Cerebral magnetic resonance imaging showed absence of the pineal gland in all three index patients. Severe
hypoplasia of the brain anterior commissure was associated with the p.L57fs17 mutation, absence of the posterior
commissure with p.R159fs47, and optic chiasma atrophy and almost complete agenesis of the corpus callosum with
p.R240X.
Conclusions: We identified two novel PAX6 mutations in families with severe aniridia. In addition to common phenotype
of aniridia and despite normal neurological examination, absence of the pineal gland and interhemispheric brain anomalies
were observed in all three index patients. The heterogeneity of PAX6 mutations and brain anomalies are highlighted. This
report emphasizes the association between aniridia and brain anomalies with or without functional impact, such as
neurodevelopment delay or auditory dysfunction.
In the majority of cases, aniridia is a panophthalmopathy
that is characterized by the absence or hypoplasia of the iris
and is associated with other ocular anomalies, such as cataract,
foveal hypoplasia, corneal opacity (pannus), coloboma,
anterior chamber angle (with secondary glaucoma), or optic
nerve malformations, mainly hypoplasia (OMIM 106210).
Mostly inherited in an autosomal dominant mode, aniridia can
have variable expressivity, and about one-third of the patients
are sporadic cases. Mutations in the Paired Box gene 6
(PAX6) located on chromosome 11p13 [1] have been shown
to cause aniridia [2]. PAX6 encodes a transcription factor
essential for the development of the structures and axes of the
eye [3]. Knocking out PAX6 from the mouse genome results
in the absence of the eye, the so-called Small eye (Sey) mouse
[4,5].
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Furthermore, PAX6 plays a major role in brain
development [6,7] where it is expressed in the telencephalon,
the diencephalon, the caudal part of the rhombencephalon, the
myelencephalon, and the spinal cord [3,8]. The early death of
a baby with a compound heterozygous PAX6 mutation has
been reported, and the brain of this child displayed major brain
and cytoarchitectonic abnormalities [9]. Brain imaging
(magnetic resonance imaging [MRI]) performed in patients
heterozygous for PAX6 mutations often reveals various
malformations as well. Absence of the brain anterior or
posterior commissure, absence of the pineal gland, and a
present but reduced in size corpus callosum have all been
reported [10-14]. These anomalies involve the brain
interhemispheric fibers and can thus affect the auditory
functions that depend on these fibers [10].
Genotype–phenotype correlations have shown that
mutations causing premature termination codons are
associated with aniridia and missense mutations are related to
non-aniridia phenotypes, such as isolated foveal hypoplasia,
microphthalmia, and optic nerve defects [15].
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The aim of this study was to analyze three families of
Egyptian origin, to describe their clinical phenotype,
including brain imaging, and to report the results of their
molecular screening. We present two novel and one known
nonsense mutations associated with brain anomalies.
METHODS
This study was approved by the Ethics Committee of the
Faculty of Medicine of the University of Alexandria, Egypt,
and was conducted in accordance to the tenets of the
Declaration of Helsinki. Written informed consent was
obtained from each participant or parent. Ten patients with
aniridia belonging to three families of Egyptian origin were
included in this study as well as six first-degree relatives
(Figure 1). The three families were from the Governorate of
Alexandria, in northwestern Egypt. All subjects underwent
full ophthalmic, general, and neurological examination,
respectively, at the Departments of Ophthalmology,
Pediatrics and Neurology of the University of Alexandria,
Egypt. Special attention was paid to assessing the presence of
associated anomalies, such as Wilms’ tumor, urogenital
anomalies, or mental retardation, in all subjects. We
performed a cerebral MRI in each index patient (Patient III-1
of Family 1, IV-3 of Family 2, and I-1 of Family 3; Table 1).
MRIs were reviewed by two different radiologists. MRI
acquisition techniques included conventional T1- and T2-
weighted multisection images (5-mm slice) on a GE Signa
HDx 1.5Tesla MRI (General Electric Company, Fairfield,
CT).
Figure 1. Pedigrees and mutation
sequences of the three Egyptian families
with autosomal dominant aniridia. Male
and female subjects are represented by
squares and circles, respectively, and
affected family members have darkened
symbols.
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Molecular analyses: DNA from patients was extracted
from peripheral leucocytes, as previously described [16].
Direct bidirectional resequencing of all PCR-amplified
coding exons and adjacent junctions was performed with the
ABI Dye Terminator, version 1 (Applied Biosystems, Foster
City, CA), in a final reaction volume of 10 μl, and
electrophoresed on a 3130XL ABI genetic analyzer (Applied
Biosystems). Sequences were compared to the reference
sequence NM_000280.3, using Chromas version 2.23
(Technelysium, Tewantin, Australia). The adenine of the
ATG translation start site was set to 1. Primers and annealing
temperature for PAX6 exons are listed in Table 2. In short,
amplification was performed in a thermal cycler (GeneAmp
9700; Applied Biosystems), in a total volume of 30 μl. Each
PCR contained 100 ng genomic DNA, 0.9 nl of each primer,
and 15 μl master mix 2× (Qiagen, Hombrechtikon,
Switzerland), with or without betaine. PCR reactions were
performed as follows: an initial denaturation step was carried
out for 10 min followed by 35 cycles of 1 min at 92 °C, 1 min
at the specific annealing temperature (Table 2), and 1 min at
72 °C. A final extension cycle at 72 °C for 10 min was
performed. Identified mutations were evaluated in 96 ethnic-
matched controls by denaturing high-performance liquid
chromatography (DHPLC) on a WAVE system
(Transgenomics, Crewe, UK). Buffer A contained 0.1 M
triethylammonium acetate (TEAA; Transgenomics). Buffer B
contained 0.1 M TEAA and 25% acetonitrile HPLC grade
(Sigma-Aldrich Co., St. Louis, MO). The flow rate was set at
1.5 ml/min, and the Buffer B gradient was increased by 5%
per min for 2 min. The optimum temperature was determined
by the Wavemaker software (Transgenomic) for each DNA
fragment, and a time shift was applied as needed (Table 2).
Initial Buffer B concentrations and temperatures for each
fragment are listed in Table 2.
RESULTS
Clinical findings: Patients clinical features and mutations
description are detailed in Table 1. All ten affected patients
from the three families had bilateral aniridia, with almost
complete absence of iris tissue at its base, and bilateral foveal
hypoplasia. Pendular nystagmus consecutive to early severely
reduced visual acuity was observed in all affected subjects,
except patient III-6 of Family 2 (Figure 1) who presented a
left exotropia. Corneal vascularization of different degrees
was observed in the three families (Figure 2). Lens
abnormalities and glaucoma were present in Families 1 and 2
only. In Family 1, the two affected subjects with glaucoma
had controlled pressure after bilateral trabeculectomy,
whereas patient III-6 of Family 2 had uncontrolled high
pressure. Systemic and neurological examinations were
normal in all ten affected subjects. In particular, no kidney or
urogenital anomalies on ultrasonography, no mental
retardation, no cerebellar abnormal signs, and no olfactory or
hearing difficulties were observed or reported.
Cerebral MRI of Patients III-1 of Family 1 showed a
severe hypoplasia of the anterior commissure of the brain and
an absent pineal gland; the posterior commissure of the brain
was normal (Figure 3A). In Patient IV-3 of Family 2, a total
absence of both the pineal gland and the posterior commissure
of the brain was observed, but the anterior commissure was
normal (Figure 3C). Patient I-1 of Family 3 harbored an
almost complete agenesis of the corpus callosum with a small
amount of remnant tissue localized at the virtual connection
between the genu and the body of the corpus callosum (Figure
4A). In the same patient, Probst bundles were identified
(Figure 4C). Concomitant ectasia of the ventricles and atrium,
hypoplasia of the optic chiasm (Figure 4C), and total absence
of the pineal gland were observed as well (Figure 4C). Both
anterior and posterior commissures of the brain were normal.
Molecular findings: In Family 1, a c.170-174delTGGGC
mutation was identified in exon 7, generating a frameshift and
an early termination 17 codons downstream (p.L57fs17). The
mutation was present at the heterozygous state in the four
affected members of Family 1 and absent in the two unaffected
subjects (Figure 1). Family 2 also exhibited an unreported
deletion. The deletion of c.475delC in exon 8 generates a
frameshift and a new stop codon 47 amino acids downstream
(p.R159fs47). This mutation was present in the three affected
subjects and absent in the two unaffected individuals (Figure
1). The two mutations were not detected in 96 ethnically
matched healthy individuals and have not been previously
reported according to the Human PAX6 Mutation Database
[17]. In Family 3, the previously described c.718C>T
(p.R240X) nonsense mutation in exon 9 [2,18,19] was
detected in the two affected members and not in the unaffected
mother (Figure 1).
DISCUSSION
We report three PAX6 mutations segregating in three families
with aniridia originating from the northwestern part of Egypt.
Two of the three mutations are novel frameshifting deletions,
and one is a previously described nonsense mutation. To our
knowledge, this is the first report of aniridia mutations from
this part of the world. It is interesting to note that the pathology
of the PAX6-related genome is far from being fully determined
when one considers that only one of the identified mutants
was already known. From a clinical point of view, the ten
patients of this series harbored common but extensive features
of ocular-isolated aniridia associated with the wide spectrum
of already described MRI brain malformations. These include
absence of the pineal gland and hypogenesis of the corpus
callosum and of the anterior or posterior commissure. The
interpretation of the observed MRI malformations is limited
by the lack of a full assessment of the neurological
development; refined examinations, such as
electroencephalogram, neurocognitive tests, or sleep study,
were not available. Nevertheless, the patients did not harbor
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Figure 2. Slit-lamp photographs. A: Right eye of patient II-7 from Family 1. Note the significant, heavy, corneal vascularization sparing the
nasal area. The iris base is very thin, almost invisible, a typical feature of aniridia. The patient was aphakic since cataract surgery performed
in childhood. Best-corrected visual acuity was 0.1. B: Right eye patient III-4 from Family 1 showing heavy corneal vascularization (pannus)
and superior dislocation of the lens. Almost no iris residual tissue is visible, as typically seen in aniridia. Note as well the small anterior polar
cataract and the associated faint peripheral cortical opacities. C and D: Right and left eye of patient IV-3 from Family 2. Note the bilateral
posterior polar cataract shaped like the petals of a flower and the superior lens dislocation. E and F: Fundus photographs. Right and left eye
of patient IV-1 from Family 2. Foveal hypoplasia is observed with macular pigment epithelium alterations.
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major neurodevelopmental delay that could be detected
clinically by a senior geneticist and pediatrician.
In a large genotype–phenotype correlation of the PAX6
Mutation Database, Tzoulaki et al. [15] established that
mutations introducing a premature termination codon (PTC)
were predominantly associated with aniridia, whereas non-
aniridia phenotypes, such as isolated foveal hypoplasia,
microphthalmia, and optic nerve defects, were predominantly
caused by missense mutations. These authors showed that the
second most frequent type of PAX6 mutations was
frameshifting insertions or deletions and missense mutations
were the third. In the present series of patients with typical
aniridia, the three identified mutations caused a PTC, and two
of them were frameshifting deletions, thus confirming the
frequent association of PTC and of frameshifting mutations
with aniridia [15].
The p.R240X mutation segregating in Family 3 has
previously been described [2,18,19] with more than 20
independent records in the PAX6 Mutation Database [17].
This mutation is a C>T transition that occurs on a CpG
dinucleotide, a structure known for its high mutability [20].
This CpG in exon 9, located in the homeobox coding region,
is a mutation hotspot since CpG dinucleotides of the last third
of PAX6 tend to be methylated and thus more inclined to
undergo spontaneous deamination of cytosine, resulting in
C>T transition [21]. A sense-strand deamination of CpG in a
CGA codon creates a termination codon CTA. It has been
proposed that nonsense-mediated decay (NMD), the
mechanism responsible for the elimination of mRNAs that
contain premature termination codons before the last exon
[22], is highly involved in aniridia since the majority of
aniridia PAX6 mutations introduce premature termination
codons [15]. Thus, NMD impedes truncated protein
formation, and loss-of-function of one allele is responsible for
the development of aniridia through haploinsufficiency. This
mechanism may explain how different mutations and different
putative truncated proteins can induce similar phenotypes.
The Family 1 and 2 unreported mutations, p.L57fs17 and
p.R159fs47, are both likely to result in haploinsufficiency
through NMD.
Hypoplasia of the anterior commissure [10,12,14], of the
posterior commissure [10], and of the corpus callosum
[10-12,14] have been reported in heterozygous carriers of
PAX6 mutations. Absence or hypoplasia of the anterior
commissure is present in up to one-third of PAX6 mutation
carriers [10,13]. Abnormal anterior MRI anomalies can be
associated with subtle neurological deficits, such as olfactory
difficulties [14], hearing difficulties [10], and deficits in
executive and social cognition [11], or with aniridia only
[12]. We did observe anomalies of these three brain structures
in our three imaged patients (Table 1). Although no brain
anomalies can yet be directly related to any specific PAX6
mutation, we report the third observation of MRI anomalies
associated with the p.R240X mutation [10,14]. In contrast
with both Sisodiya et al. [14] and Bamiou et al. [10] who
reported a hypoplastic anterior commissure but a normal
corpus callosum, we observed in Patient I-1 of Family 3 an
almost complete agenesis of the corpus callosum with a
normal anterior commissure (Table 1,Figure 4C).
Interestingly, we observed Probst bundles in this patient
Figure 3. Axial cerebral T2-weighted magnetic resonance images. A: Patient III-1 from Family 1. Dashed arrow: severe hypoplasia of the
anterior commissure. Arrow head: normal posterior commissure. Lower arrow: absence of the pineal gland. B: Normal magnetic resonance
imaging (MRI) images. Dashed arrow: normal anterior commissure. Arrow head: normal posterior commissure. Lower arrow: normal pineal
gland. C:  Patient IV-3 from Family 2. Dashed arrow: normal anterior commissure. Arrow head: absent posterior commissure. Lower arrow:
absent pineal gland.
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(Figure 4C), which highlights the severity of the corpus
callosum hypogenesis in this case. Indeed, Probst bundles
represent fiber tracts that grow caudally along the medial
surface of the ipsilateral cerebral hemisphere that would have
crossed the midline in the case of normal corpus callosum
development [23]; their presence is common in patients with
corpus callosum hypogenesis and twice as frequent in patients
with corpus callosum agenesis [24].
We hypothesize that a specific mutation can cause brain
anomalies but that the brain anomaly can be expressed
differently. Being a transcription factor, PAX6 interacts with
several brain developmental genes and transcription factors,
such as the Homeobox gene expressed in ES cells, the Hesx1
gene [3], whose interaction with PAX6 could be altered by the
presence of a mutant protein causing corpus callosum and
brain commissure hypogenesis. It has recently been
demonstrated in mouse that the transcription factors Empty
spiracles homeobox 2, Emx2 and Pax6 are essential for
cortical regionalization at the beginning of neuronogenesis
[25]. From this perspective, one can hypothesize that
abnormal interaction between mutated PAX6 protein and a
normal EMX2 protein could be responsible for the presence
of the interhemispheric brain anomalies. Moreover, the
possibility of digenism is not excluded with the presence of
an undetected EMX2 mutation added to the PAX6 one to result
in corpus callosum and commissure dysgenesis. Last, the
existence of at least two promoters is described in the literature
to mediate Pax6 expression in different tissues [26,27]. Thus,
one promoter mediates expression in the brain, and
differential PAX6 transcription through alternate promoter
usage could be involved in neural development [28].
Figure 4. Coronal cerebral T2-weighted
magnetic resonance images. A: Patient
I-1 from Family 3. Dashed arrow shows
severe hypogenesis of the corpus
callosum with small amount of remnant
tissue localized at the virtual connection
between the genu and the body of the
corpus callosum; arrow head shows the
atrophic optic chiasm. B: Normal MRI
images. Dashed arrow shows normal
corpus callosum and arrow head shows
normal optic chiasm. C: Patient I-1 from
Family 3. Dashed arrow shows lateral
callosal bundles of Probst, which are
hemispheric connection fibers that did
not cross the midline and that are seen
in callosal dysgenesis. Superomedial
margins of the lateral ventricles are
indented by the Probst bundles. Arrow
head shows remnants of the corpus
callosum. Lower arrow shows normal
posterior commissure. D: Normal MRI
image with dashed arrow pointing
normal corpus callosum.
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The auditory fibers travel through the interhemispheric
pathways, and it has been demonstrated that children with
PAX6 mutations and abnormalities of the interhemispheric
pathways on MRI harbor reduced auditory capacities even in
the presence of normal audiograms [10]. We did not observe
any major clinical auditory deficits in any of the ten studied
patients, although the three patients with available MRIs
showed abnormal interhemispheric pathways. However we
cannot conclude on the auditory status since we did not
perform any specific tests, including the study of auditory-
evoked potentials.
Mitchell et al. [13] published an MRI study of 24 aniridia
patients with PAX6 mutations and found absence of the pineal
gland in 13/24 patients (54%). These authors concluded that
this observation may be common in aniridia patients. Indeed,
we have previously reported absence of the pineal gland in
aniridia patients [29] as we do in the three patients of the
present series in whom we performed MRI. As previously
mentioned, sleep study was not performed and thus we could
not assess the functional consequences of the absence of
pineal glands. Mice homozygous for mutations in the Pax6
gene harbor a wide variety of neurodevelopmental
abnormalities, including absence of the corpus callosum and
pineal gland [30,31].
PAX6 affects the development and function of the central
nervous system and the eye as well as the pancreas and the
hypothalamopituitary axis through the hypothalamus [3],
which shares with the retina a common embryologic origin—
the neural plate. Unfortunately, we were not able to perform
electroretinography or endocrine testing to study the effect of
the PAX6 mutations on the retina and hypothalamopituitary
axis.
Finally, WAGR syndrome (OMIM 194072), which
includes Wilms’ tumor, aniridia, genitourinary anomalies,
and mental retardation, is caused by either microscopic or
submicroscopic deletion of chromosome 11p13-p12 in a
region containing both the Wilms tumor 1, WT1 gene and the
PAX6 genes. A contiguous syndrome, the WAGRO syndrome
(OMIM 612469), includes the features of WAGR with obesity
and is caused by a similar deletion that includes the Brain-
derived neurotrophic factor, BDNF gene as well. Both
syndromes were clinically excluded by normal kidney and
urogenital ultrasonography performed on our patients.
In summary, we describe three mutations found in three
families from northwestern Egypt, adding two novel
mutations to the existing spectrum of PAX6 mutations. Two
of the three mutations are frameshifting small deletions and
one is a previously described nonsense mutation. While the
ten familial aniridia patients of this series harbored typical
features of ocular-isolated aniridia, we observed a wide
spectrum of MRI brain malformations, including absence of
the pineal gland, hypogenesis of the corpus callosum with
Probst bundles, and hypoplasia of the anterior or posterior
commissure in patients not harboring major neurological
development anomalies. Correlation between phenotype and
genotype of PAX6 mutations is still in its infancy in regard to
brain malformations. The wide spectrum of PAX6-related
anomalies and the fact that aniridia is frequently caused by
PAX6 mutations should prompt physicians facing aniridia to
perform an examination of the central nervous system (at least
with an MRI), an ultrasonography of the kidney and of the
urinary pathways, a study of the kidney functions, and most
importantly a complete assessment of the pituitary hormones
and hypothalamic-releasing hormones.
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